Listed

BioCardia, Inc.

BCDANasdaqCIK 925741HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2025
Operating income−$1.6m, Q2 FY2026
Net income−$1.6m, Q2 FY2026
BioCardia, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k357Revenue, Q3 FY2023, three months to 2023-09-30$357.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure13.0Revenue, Q4 FY2023, three months to 2023-12-31$13.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-03-26, accession 0001437749-25-009397. Derived: 12-month figure less the 9-month figure.Report this figure55.0Revenue, Q1 FY2024, three months to 2024-03-31$55.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure3.0Revenue, Q2 FY2024, three months to 2024-06-30$3.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Cost of revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k1,872Research and development, Q3 FY2023, three months to 2023-09-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure1,156Research and development, Q4 FY2023, three months to 2023-12-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-26, accession 0001437749-25-009397. Derived: 12-month figure less the 9-month figure.Report this figure1,241Research and development, Q1 FY2024, three months to 2024-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure800Research and development, Q2 FY2024, three months to 2024-06-30$800.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure931Research and development, Q3 FY2024, three months to 2024-09-30$931.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure1,415Research and development, Q4 FY2024, three months to 2024-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure1,530Research and development, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure1,368Research and development, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure936Research and development, Q3 FY2025, three months to 2025-09-30$936.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure1,128Research and development, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure1,235Research and development, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure893Research and development, Q2 FY2026, three months to 2026-06-30$893.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Selling, general and administrative$k1,083Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure941Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$941.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-26, accession 0001437749-25-009397. Derived: 12-month figure less the 9-month figure.Report this figure1,089Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure852Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$852.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure825Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$825.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure906Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$906.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure1,196Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure683Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$683.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure552Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$552.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure885Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$885.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure1,031Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$1.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure730Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$730.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Operating income$k(2,598)Operating income, Q3 FY2023, three months to 2023-09-30−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure(2,084)Operating income, Q4 FY2023, three months to 2023-12-31−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-26, accession 0001437749-25-009397. Derived: 12-month figure less the 9-month figure.Report this figure(2,275)Operating income, Q1 FY2024, three months to 2024-03-31−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure(1,649)Operating income, Q2 FY2024, three months to 2024-06-30−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure(1,756)Operating income, Q3 FY2024, three months to 2024-09-30−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure(2,321)Operating income, Q4 FY2024, three months to 2024-12-31−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure(2,726)Operating income, Q1 FY2025, three months to 2025-03-31−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure(2,051)Operating income, Q2 FY2025, three months to 2025-06-30−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure(1,488)Operating income, Q3 FY2025, three months to 2025-09-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure(2,013)Operating income, Q4 FY2025, three months to 2025-12-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure(2,266)Operating income, Q1 FY2026, three months to 2026-03-31−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure(1,623)Operating income, Q2 FY2026, three months to 2026-06-30−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$k0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-26, accession 0001437749-25-009397. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Net income$k(2,574)Net income, Q3 FY2023, three months to 2023-09-30−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure(2,072)Net income, Q4 FY2023, three months to 2023-12-31−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-26, accession 0001437749-25-009397. Derived: 12-month figure less the 9-month figure.Report this figure(2,267)Net income, Q1 FY2024, three months to 2024-03-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure(1,646)Net income, Q2 FY2024, three months to 2024-06-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure(1,737)Net income, Q3 FY2024, three months to 2024-09-30−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure(2,296)Net income, Q4 FY2024, three months to 2024-12-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure(2,712)Net income, Q1 FY2025, three months to 2025-03-31−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure(2,049)Net income, Q2 FY2025, three months to 2025-06-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure(1,483)Net income, Q3 FY2025, three months to 2025-09-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure(1,984)Net income, Q4 FY2025, three months to 2025-12-31−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure(2,259)Net income, Q1 FY2026, three months to 2026-03-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure(1,613)Net income, Q2 FY2026, three months to 2026-06-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reportednot reportednot reportednot reported(0.59)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure(0.40)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figurenot reportednot reported(0.21)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figurenot reported
Basic EPS$ per share(1.79)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figurenot reported(1.35)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure(0.88)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure(0.61)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figurenot reported(0.59)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure(0.40)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure(0.24)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figurenot reported(0.21)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure(0.13)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure

Balance sheet

Cash and equivalents$4.1m, Q2 FY2026
Shareholders' equity$2.7m, Q2 FY2026
BioCardia, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$k1,835Cash and equivalents, Q3 FY2023, at 2023-09-30$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001437749-23-030938.Report this figure1,103Cash and equivalents, FY2023, at 2023-12-31$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-26, accession 0001437749-25-009397.Report this figure949Cash and equivalents, Q1 FY2024, at 2024-03-31$949.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001437749-24-016611.Report this figure1,421Cash and equivalents, Q2 FY2024, at 2024-06-30$1.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001437749-24-026310.Report this figure4,930Cash and equivalents, Q3 FY2024, at 2024-09-30$4.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure2,371Cash and equivalents, FY2024, at 2024-12-31$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-24, accession 0001437749-26-009587.Report this figure949Cash and equivalents, Q1 FY2025, at 2025-03-31$949.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure980Cash and equivalents, Q2 FY2025, at 2025-06-30$980.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure5,287Cash and equivalents, Q3 FY2025, at 2025-09-30$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure2,496Cash and equivalents, FY2025, at 2025-12-31$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure951Cash and equivalents, Q1 FY2026, at 2026-03-31$951.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure4,117Cash and equivalents, Q2 FY2026, at 2026-06-30$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Current assets$k2,116Current assets, Q3 FY2023, at 2023-09-30$2.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001437749-23-030938.Report this figure1,461Current assets, FY2023, at 2023-12-31$1.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-26, accession 0001437749-25-009397.Report this figure1,259Current assets, Q1 FY2024, at 2024-03-31$1.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001437749-24-016611.Report this figure1,573Current assets, Q2 FY2024, at 2024-06-30$1.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001437749-24-026310.Report this figure5,056Current assets, Q3 FY2024, at 2024-09-30$5.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure2,622Current assets, FY2024, at 2024-12-31$2.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-24, accession 0001437749-26-009587.Report this figure1,173Current assets, Q1 FY2025, at 2025-03-31$1.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure1,199Current assets, Q2 FY2025, at 2025-06-30$1.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure5,365Current assets, Q3 FY2025, at 2025-09-30$5.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure2,732Current assets, FY2025, at 2025-12-31$2.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure1,140Current assets, Q1 FY2026, at 2026-03-31$1.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure4,298Current assets, Q2 FY2026, at 2026-06-30$4.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Total assets$k3,747Total assets, Q3 FY2023, at 2023-09-30$3.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001437749-23-030938.Report this figure2,987Total assets, FY2023, at 2023-12-31$3.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-26, accession 0001437749-25-009397.Report this figure2,679Total assets, Q1 FY2024, at 2024-03-31$2.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001437749-24-016611.Report this figure2,890Total assets, Q2 FY2024, at 2024-06-30$2.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001437749-24-026310.Report this figure6,267Total assets, Q3 FY2024, at 2024-09-30$6.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure3,724Total assets, FY2024, at 2024-12-31$3.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-24, accession 0001437749-26-009587.Report this figure2,166Total assets, Q1 FY2025, at 2025-03-31$2.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure2,089Total assets, Q2 FY2025, at 2025-06-30$2.1m. XBRL concept us-gaap:Assets. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure6,148Total assets, Q3 FY2025, at 2025-09-30$6.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure3,413Total assets, FY2025, at 2025-12-31$3.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure1,712Total assets, Q1 FY2026, at 2026-03-31$1.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure4,755Total assets, Q2 FY2026, at 2026-06-30$4.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Current liabilities$k3,330Current liabilities, Q3 FY2023, at 2023-09-30$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001437749-23-030938.Report this figure3,608Current liabilities, FY2023, at 2023-12-31$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-26, accession 0001437749-25-009397.Report this figure4,071Current liabilities, Q1 FY2024, at 2024-03-31$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001437749-24-016611.Report this figure4,071Current liabilities, Q2 FY2024, at 2024-06-30$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001437749-24-026310.Report this figure2,840Current liabilities, Q3 FY2024, at 2024-09-30$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure2,321Current liabilities, FY2024, at 2024-12-31$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-24, accession 0001437749-26-009587.Report this figure3,234Current liabilities, Q1 FY2025, at 2025-03-31$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure3,642Current liabilities, Q2 FY2025, at 2025-06-30$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure3,310Current liabilities, Q3 FY2025, at 2025-09-30$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure2,432Current liabilities, FY2025, at 2025-12-31$2.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure2,778Current liabilities, Q1 FY2026, at 2026-03-31$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure2,055Current liabilities, Q2 FY2026, at 2026-06-30$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Total liabilities$k4,407Total liabilities, Q3 FY2023, at 2023-09-30$4.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001437749-23-030938.Report this figure4,590Total liabilities, FY2023, at 2023-12-31$4.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-26, accession 0001437749-25-009397.Report this figure4,954Total liabilities, Q1 FY2024, at 2024-03-31$5.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001437749-24-016611.Report this figure4,851Total liabilities, Q2 FY2024, at 2024-06-30$4.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001437749-24-026310.Report this figure3,514Total liabilities, Q3 FY2024, at 2024-09-30$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure2,887Total liabilities, FY2024, at 2024-12-31$2.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-24, accession 0001437749-26-009587.Report this figure3,686Total liabilities, Q1 FY2025, at 2025-03-31$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure3,975Total liabilities, Q2 FY2025, at 2025-06-30$4.0m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197.Report this figure3,521Total liabilities, Q3 FY2025, at 2025-09-30$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure2,518Total liabilities, FY2025, at 2025-12-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure2,778Total liabilities, Q1 FY2026, at 2026-03-31$2.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure2,055Total liabilities, Q2 FY2026, at 2026-06-30$2.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure
Shareholders' equity$k(660)Shareholders' equity, Q3 FY2023, at 2023-09-30−$660.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001437749-24-034896.Report this figure(1,603)Shareholders' equity, FY2023, at 2023-12-31−$1.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-24, accession 0001437749-26-009587.Report this figure(2,275)Shareholders' equity, Q1 FY2024, at 2024-03-31−$2.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure(1,961)Shareholders' equity, Q2 FY2024, at 2024-06-30−$2.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure2,753Shareholders' equity, Q3 FY2024, at 2024-09-30$2.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure837Shareholders' equity, FY2024, at 2024-12-31$837.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure(1,520)Shareholders' equity, Q1 FY2025, at 2025-03-31−$1.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure(1,886)Shareholders' equity, Q2 FY2025, at 2025-06-30−$1.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure2,627Shareholders' equity, Q3 FY2025, at 2025-09-30$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001437749-25-034437.Report this figure895Shareholders' equity, FY2025, at 2025-12-31$895.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure(1,066)Shareholders' equity, Q1 FY2026, at 2026-03-31−$1.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure2,700Shareholders' equity, Q2 FY2026, at 2026-06-30$2.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure

Cash flow

Operating cash flow−$1.7m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
BioCardia, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(2,412)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001437749-24-034896. Derived: 9-month figure less the 6-month figure.Report this figure(1,851)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-26, accession 0001437749-25-009397. Derived: 12-month figure less the 9-month figure.Report this figure(1,530)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001437749-25-016831.Report this figure(1,312)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197. Derived: 6-month figure less the 3-month figure.Report this figure(2,611)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001437749-25-034437. Derived: 9-month figure less the 6-month figure.Report this figure(2,433)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure(1,618)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure(1,649)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001437749-26-027315. Derived: 6-month figure less the 3-month figure.Report this figure(1,672)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001437749-25-034437. Derived: 9-month figure less the 6-month figure.Report this figure(2,497)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure(1,659)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure(1,735)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001437749-26-027315. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001437749-24-034896. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-26, accession 0001437749-25-009397. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-14, accession 0001437749-24-016611.Report this figure3.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q/A filed 2025-10-29, accession 0001437749-25-032197. Derived: 6-month figure less the 3-month figure.Report this figure2.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001437749-25-034437. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure1.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001437749-26-027315. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001437749-25-034437. Derived: 9-month figure less the 6-month figure.Report this figure6.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001437749-26-009587. Derived: 12-month figure less the 9-month figure.Report this figure3.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001437749-26-027315. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)10.81m, Q1 FY2026
BioCardia, Inc., shares, quarterly
Line itemUnitQ1 FY20142014-03-31Q2 FY20142014-06-30Q3 FY20142014-09-30Q1 FY20152015-03-31Q2 FY20152015-06-30Q3 FY20152015-09-30Q1 FY20162016-03-31Q2 FY20162016-06-30Q3 FY20162016-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q1 FY20262026-03-31
Diluted shares (weighted)m shares230Diluted shares (weighted), Q1 FY2014, three months to 2014-03-31230,293,141 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2015-05-12, accession 0001136261-15-000123.Report this figure230Diluted shares (weighted), Q2 FY2014, three months to 2014-06-30230,293,141 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2015-08-12, accession 0001136261-15-000248.Report this figure230Diluted shares (weighted), Q3 FY2014, three months to 2014-09-30230,293,141 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2015-10-29, accession 0001136261-15-000302.Report this figure230Diluted shares (weighted), Q1 FY2015, three months to 2015-03-31230,293,141 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2016-05-03, accession 0001136261-16-000456.Report this figure230Diluted shares (weighted), Q2 FY2015, three months to 2015-06-30230,293,141 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2016-08-02, accession 0001136261-16-000580.Report this figure230Diluted shares (weighted), Q3 FY2015, three months to 2015-09-30230,293,141 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2016-10-17, accession 0001136261-16-000628.Report this figure230Diluted shares (weighted), Q1 FY2016, three months to 2016-03-31230,293,141 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2016-05-03, accession 0001136261-16-000456.Report this figure230Diluted shares (weighted), Q2 FY2016, three months to 2016-06-30230,293,141 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2016-08-02, accession 0001136261-16-000580.Report this figure231Diluted shares (weighted), Q3 FY2016, three months to 2016-09-30230,537,706 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2016-10-17, accession 0001136261-16-000628.Report this figure4.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-314,635,764 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure5.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-305,059,736 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure10.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3110,812,419 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001437749-26-017221.Report this figure

Shares outstanding: 15.14mShares outstanding, period not labelled, at 2026-08-1115,138,782 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001437749-26-027315.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. Listed shows no prices and gives no investment advice.